Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04773782
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-15
First Post:
2021-02-09
Brief Title:
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-09
First Submit QC Date:
February 25 2021
Study First Post Date:
2021-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-20
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL